Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice

Oncogene

Volumn 17, Issue 16, 1998, Pages 2125-2135

  Hilbert, David M ^a,d   Theisen, Patrick W ^b,c   Rudikoff, Eva K ^b   Bauer, Steven R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c Baltimore Res and Educ Foundation   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

abl myc retrovirus; IL 7 signal transduction; JAK STAT signaling; Pre B lymphomagenesis; raf myc retrovirus

Indexed keywords

INTERLEUKIN 7; RAF PROTEIN;

ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE MYC; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RETROVIRUS; SIGNAL TRANSDUCTION; TUMOR;

EID: 0032558844     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202134     Document Type: Article

References (38)

1. Anderson PN and Potter M. (1969). Nature, 222, 994-995.
2. Anderson SM, Carroll PM and Lee FD. (1990). Oncogene, 5, 317-325.
3. Bender TP and Kuehl WM. (1987). Immunol. J., 139, 3822-3827.
4. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
5. Corcoran AE, Smart FM, Cowling RJ, Crompton T, Owen MJ and Venkitaraman AR. (1996). EMBO. J., 15, 1924-1932.
6. Danial NN, Pernis A and Rothman PB. (1995). Science, 269, 1875-1877.
7. Dean M, Cleveland JL, Rapp UR and Ihle JN. (1987). Oncogene Res., 1, 279-296.
8. Ghia P, Gratwohl A, Signer E, Winkler TH, Melchers F and Rolink AG. (1995). Eur J. Immunol., 25, 3108-3114.
9. Hilbert DM, Shen Y, Rapp U and Rudikoff S. (1995). Proc. Natl. Acad. Sci. USA, 92, 649-653.
10. Hilbert DM, Migone TS, Kopf M, Leonard WJ and Rudikoff S. (1996). Immunity, 5, 81-89.
11. Hubert DM, Pumphrey JG, Troppmair J, Rapp UR and Rudikoff S. (1993). Oncogene, 8, 1993-2000.
12. Johnston JA, Wang LM, Hanson EP, Sun XJ, White MF, Oakes SA, Pierce JH and O'Shea JJ. (1995). J. Biol. Chem., 270, 28527-28530.
13. Kudo A and Melchers F. (1987). EMBO. J., 6, 2267-2272.
14. Laneuville P, Sun G, Timm M and Vekemans M. (1992). Blood, 80, 1788-1797.
15. Largaespada DA, Kaehler DA, Mishak H, Weissinger K, Potter M, Mushinski JF and Risser R. (1992). Oncogene, 7, 811-819.
16. Lin AY and Li FP. (1996). Etiology and Epidemiology of Chronic Leukemias. In Neoplastic Diseases of the Blood, Wiernik PH, Canellos GP, Dutcher JP and Kyle RA (eds). Churchill Livingston: New York.
17. McCubrey JA, Smith SR, Algate PA, DeVente JE, White MK and Steelman LS. (1993). Oncogen, 8, 2905-2915.
18. Merwin RM and Algire GH. (1959). Proc. Soc. Exp. Biol. Med., 101, 437-439.
19. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G and Leonard WJ. (1995). Science, 269, 79-81.
20. Okahe T, Bauer SR and Kudo A. (1992). Eur. J. Immunol., 22, 31-36.
21. Poplack DG, Kun LE, Cassady JR and Pizzo PA. (1989). Leukemias and lymphomas of childhood. In: Cancer: Principles and Practice of Oncology. Third Edition. DeVita VT Jr, et al. (eds) Lippincott: Philadelphia. pp. 1671-1695.
22. Potter M and Boyce C. (1962). Nature, 193, 1086-1087.
23. Potter M, Morrison S and Miller F. (1995). Curr. Top. Microbiol. Immunol., 194, 83-91.
24. Rapp UR, Cleveland JL, Brightman K, Scott A and Ihle JN. (1985). Nature, 317, 434-438.
25. Rolink A, Haasner D, Nishikawa S and Melchers F. (1993). Blood, 81, 2290-2300.
26. Rolink A, Kudo A and Melchers F. (1991). Biochem. Soc. Trans., 19, 275-276.
27. Rolink A and Melchers F. (1993). Advances in Immunology, 53, 123-156.
28. Rolink A and Melchers F. (1991). Cell, 66, 1081-1094.
29. Rose FV and Reddy EP. (1992). Virology, 188, 650-656.
30. Rosenberg N. (1982). Curr. Top Microbiol. Immunol., 101, 95-126.
31. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular Cloning. A Laboratory Manual, 2 Edition (Cold Spring Harbor).
32. Scheuermann RH and Bauer SR. (1993). Methods Enzymol., 218, 446-473.
33. Silva S, Sugiyama H, Babonits M, Wiener F and Klein G. (1991). Int. J. Cancer, 49, 224-228.
34. Smith MR. (1996). Curr. Probl. Cancer, 20, 6-77.
35. Troppmair J, Potter M, Wax JS and Rapp UR. (1989). Proc. Natl. Acad. Sci. USA, 86, 9941-9945.
36. Weissinger EM, Mischak H, Goodnight J, Davidson WF and Mushinski JF. (1993). Mol. Cell. Biol., 13, 2578-2585.
37. Whitlock CA and Witte ON. (1981). J. Virol., 40, 577-584.
38. Wiernik PH, Canellos GP, Kutcher JP and Kyle RA. (1996). Neoplastic Diseases of Blood, 3rd Edition. Churchill Livingston: New York.